POSaBIT Systems Corporation (the “Company”) (formerly Foreshore Exploration Partners Corp.), a leading financial technology company delivering unique blockchain-enabled payment processing and point-of-sale (POS) systems for cash-only businesses, is pleased to announce, further to its news releases of June 11, 2018, December 17, 2018 and March 29, 2019, the completion of its reverse takeover transaction (the “Transaction”) with POSaBIT, Inc.

In connection with the Transaction, the Company has delisted from the TSX Venture Exchange and has obtained conditional listing approval of the Canadian Securities Exchange (the “CSE”) for the listing of the Company’s common shares on the CSE. The common shares are expected to commence trading on Monday, April 8, 2019 under the ticker symbol “PBIT”.

Certain shares issued to the principals of the Company are subject to escrow conditions required by applicable securities laws and policies of the CSE.

Tormont Group Inc. acted as advisor to POSaBIT, Inc. in connection with the Transaction.

Further details of the Transaction are set out in the final prospectus dated March 25, 2019 of the Company, a copy of which is available under the Company’s SEDAR profile at www.sedar.com.

Concurrent with closing of the Transaction, Chris Beltgens, Benjamin Gelber and Toby Pierce have resigned as directors of the Company and Ryan Hamlin, Jon Baugher, Jeff Dossett, Michael Markette and Paul Fiore have been appointed directors of the Company. Ryan Hamlin has been appointed President and Chief Executive Officer, Jon Baugher has been appointed Chief Revenue Officer, Andrew Sweet has been appointed Chief Technology Officer and Stephen Gledhill has been appointed Chief Financial Officer and Corporate Secretary.

Pursuant to the Transaction, Ryan Hamlin, 1128 8th Street, Kirkland, Washington, 98033, has acquired 10,647,702 common shares of the Company, representing 14% of the outstanding common shares of the Company. Of such shares, 10,222,702 common shares were issued in exchange for shares of POSaBIT, Inc. pursuant to the plan of merger, and 425,000 common shares were purchased from a director of the Company. Mr. Hamlin acquired the shares for investment purposes and may, depending on market and other conditions, increase or decrease his beneficial ownership, control or direction over securities of the Company through market transactions, private agreements or otherwise. This news release is issued pursuant to National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues. Further information will be included in the early warning report to be filed in connection with the acquisition, which will be available at www.sedar.com under the Company’s profile.

Forward-Looking Statements

This news release contains certain “forward looking statements” including statements relating to the listing with the CSE. Such forward-looking statements involve risks and uncertainties, both known and unknown. The results or events depicted in these forward-looking statements may differ materially from actual results or events. In addition to other factors and assumptions which may be identified herein, assumptions have been made regarding and are implicit in, among other things: receipt of regulatory approvals, the state of the capital markets, tax issues associated with doing business internationally, the ability of POSaBIT to successfully manage the risks inherent in pursuing business opportunities in the payment processing and technology industry, and the ability of POSaBIT to obtain qualified staff, equipment and services in a timely and cost efficient manner to develop its business. Any forward-looking statement reflects information available to the Company as of the date of this news release and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise.


POSaBIT is a financial technology company that delivers unique and innovative, blockchain-enabled payment processing and point-of-sale systems for cash-only businesses. POSaBIT specializes in resolving pain points for complex, high-risk, emerging industries like cannabis with an all-in-one solution that is compliant, user-friendly and utilizes top-of-the-line hardware. POSaBIT’s unique solution provides a safer and transparent environment for merchants while creating a better overall experience for the consumer. For additional information, visit: www.posabit.com.


Investor Relations:
Chelsea Lish
The Blueshirt Group for POSaBIT

Media Relations:
Katie North
The Blueshirt Group for POSaBIT

Ryan Hamlin
Co-founder and CEO of POSaBIT

Source: www.businesswire.com

 BioHarvest Sciences Inc. (CSE: BHSC) (the “Company” or “BioHarvest”) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). Ilan Sobel, CEO of BHSC, will host the event and discuss progress on Bioharvest’s Growth Plan, which will include highlights of the 2020 milestones achieved, key business capabilities built, and will provide an important overview of 2021 Priorities.

The presentation will be approximately 35 minutes, followed by a live question and answer session.

Keep reading... Show less

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”), reports that it has sold its 50% interest in Cobra Ventures Inc. (“Cobra”), which sale included all funds previously advanced by World Class to Cobra, to the remaining shareholder of Cobra, for $2,500,000 in cash

An investment group led by Richard Goldstein retains 100% control of Cobra, and its senior secured debenture of Hydrx Farms Ltd. (“Hydrx”), acquired by Cobra in October 2020.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Kurt Schmidt, President and Chief Executive Officer, will speak at the 24th Annual CIBC Western Institutional Investor Conference on Friday, January 22, 2021 at 4:10 p.m. EST.

A recording will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations .

Keep reading... Show less
  • Disease control of root-rot Aphanomyces zoospores in laboratory tests.
  • Outstanding Efficacy: 100% control at economic application rates within 24 hours.
  • Aphanomyces is a soil-borne root-rot disease that destroys peas, lentils, and legume crops.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce successful laboratory test results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces”) via an independent third party facility: 100% control at economic application rates within 24 hours. MustGrow will now advance to larger scale greenhouse and field tests. Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

MustGrow’s remarkably safe and effective organic biopesticide is plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, pests, and weeds with an organic food-grade biopesticide.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced the hiring of CPG industry veteran Ty Gent as the Company’s new Chief Operating Officer (“COO”). As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005322/en/

Keep reading... Show less